saathii_orc-Browse ORC
ORC
ORC You are not signed in!
 
 Search   Sitemap   Help   Sign In
You are here: ORC Home >  E-LIBRARY >  Library Resources
 
Antiretroviral Drug Resistance and Toxicities: Incremental Advances in Our Understanding and Their Implications for Patient Care
Posted by: librarian
Updated: 2005-12-28 23:33:13
Category: ORC Home > E-LIBRARY > Library Resources
 
Add to E-Library
URL http://www.medscape.com/viewarticle/511543  (Text Version)
A gist of the contents at the URL: Antiretroviral Drug Resistance and Toxicities: Incremental Advances in Our Understanding and Their Implications for Patient Care.


Disclosures
Jeffrey P. Nadler MD, December 29, 2005.



Introduction

Attendees of the 3rd IAS Conference on HIV Pathogenesis and Treatment learned new information on complications related to HIV and its treatment as well as important new drug resistance data, which are discussed in the second part of this report. Much of the new data was driven by pharmaceutical companies positioning their agents in the context of cardiovascular and metabolic disease risk. There was a bit more on decreased bone mineral density (especially from a French cohort), a review of previously presented data on renal dysfunction, and a poster that explored the link between hypertriglyceridemia and diabetes causation. There was also some substantial information on resistance issues in the setting of prevention of mother-to-child transmission (MTCT) and in the developing world in general, as well as the impact of HIV reinfection or recombination of 2 or more viral strains.


There was much incremental information on both the complications of HIV therapy and antiretroviral drug resistance at the 3rd IAS Conference on HIV Pathogenesis and Treatment. The field of HIV medicine continues to evolve incrementally, with data from these studies and many others allowing clinicians to further optimize patient care.
 
 
Library Resources